rs34670941

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_025074.7(FRAS1):​c.10877T>C​(p.Val3626Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.108 in 1,598,906 control chromosomes in the GnomAD database, including 10,137 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1358 hom., cov: 33)
Exomes 𝑓: 0.11 ( 8779 hom. )

Consequence

FRAS1
NM_025074.7 missense

Scores

13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.371

Publications

15 publications found
Variant links:
Genes affected
FRAS1 (HGNC:19185): (Fraser extracellular matrix complex subunit 1) This gene encodes an extracellular matrix protein that appears to function in the regulation of epidermal-basement membrane adhesion and organogenesis during development. Mutations in this gene cause Fraser syndrome, a multisystem malformation that can include craniofacial, urogenital and respiratory system abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
FRAS1 Gene-Disease associations (from GenCC):
  • Fraser syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Fraser syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0020789206).
BP6
Variant 4-78526609-T-C is Benign according to our data. Variant chr4-78526609-T-C is described in ClinVar as Benign. ClinVar VariationId is 261799.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.222 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FRAS1NM_025074.7 linkc.10877T>C p.Val3626Ala missense_variant Exon 70 of 74 ENST00000512123.4 NP_079350.5 Q86XX4-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FRAS1ENST00000512123.4 linkc.10877T>C p.Val3626Ala missense_variant Exon 70 of 74 5 NM_025074.7 ENSP00000422834.2 Q86XX4-2

Frequencies

GnomAD3 genomes
AF:
0.128
AC:
19434
AN:
152056
Hom.:
1356
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.170
Gnomad AMI
AF:
0.105
Gnomad AMR
AF:
0.115
Gnomad ASJ
AF:
0.134
Gnomad EAS
AF:
0.233
Gnomad SAS
AF:
0.119
Gnomad FIN
AF:
0.134
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.0972
Gnomad OTH
AF:
0.116
GnomAD2 exomes
AF:
0.118
AC:
26959
AN:
228754
AF XY:
0.116
show subpopulations
Gnomad AFR exome
AF:
0.166
Gnomad AMR exome
AF:
0.0915
Gnomad ASJ exome
AF:
0.135
Gnomad EAS exome
AF:
0.228
Gnomad FIN exome
AF:
0.136
Gnomad NFE exome
AF:
0.0984
Gnomad OTH exome
AF:
0.103
GnomAD4 exome
AF:
0.106
AC:
153208
AN:
1446732
Hom.:
8779
Cov.:
30
AF XY:
0.106
AC XY:
75965
AN XY:
718136
show subpopulations
African (AFR)
AF:
0.176
AC:
5804
AN:
33042
American (AMR)
AF:
0.0936
AC:
4011
AN:
42874
Ashkenazi Jewish (ASJ)
AF:
0.134
AC:
3448
AN:
25802
East Asian (EAS)
AF:
0.209
AC:
8108
AN:
38876
South Asian (SAS)
AF:
0.117
AC:
9660
AN:
82628
European-Finnish (FIN)
AF:
0.141
AC:
7443
AN:
52738
Middle Eastern (MID)
AF:
0.0892
AC:
512
AN:
5738
European-Non Finnish (NFE)
AF:
0.0970
AC:
107155
AN:
1105174
Other (OTH)
AF:
0.118
AC:
7067
AN:
59860
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
6630
13260
19890
26520
33150
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4180
8360
12540
16720
20900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.128
AC:
19446
AN:
152174
Hom.:
1358
Cov.:
33
AF XY:
0.130
AC XY:
9707
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.170
AC:
7056
AN:
41504
American (AMR)
AF:
0.115
AC:
1755
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.134
AC:
464
AN:
3472
East Asian (EAS)
AF:
0.233
AC:
1208
AN:
5180
South Asian (SAS)
AF:
0.118
AC:
568
AN:
4818
European-Finnish (FIN)
AF:
0.134
AC:
1420
AN:
10602
Middle Eastern (MID)
AF:
0.0952
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
0.0972
AC:
6610
AN:
67986
Other (OTH)
AF:
0.114
AC:
241
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
864
1728
2591
3455
4319
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
212
424
636
848
1060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.110
Hom.:
2609
Bravo
AF:
0.126
TwinsUK
AF:
0.0968
AC:
359
ALSPAC
AF:
0.0963
AC:
371
ESP6500AA
AF:
0.163
AC:
652
ESP6500EA
AF:
0.0998
AC:
832
ExAC
AF:
0.116
AC:
13940
Asia WGS
AF:
0.193
AC:
671
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fraser syndrome 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
1.3
DANN
Benign
0.71
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.094
N
LIST_S2
Benign
0.61
T
MetaRNN
Benign
0.0021
T
MetaSVM
Benign
-0.91
T
PhyloP100
0.37
PrimateAI
Benign
0.33
T
Sift4G
Benign
0.27
T
Vest4
0.016
ClinPred
0.0027
T
GERP RS
-0.78
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34670941; hg19: chr4-79447763; COSMIC: COSV53617197; API